SOAT1 and small cell lung carcinoma: L-SCLC exhibited a higher enrichment score of immune-related pathways (Additional file 1: Figure S5E) than AS-SCLC, including myeloid cell activation, JAK/STAT signaling, regulation of cytokine production, and inflammatory response.